Veronique Neumeister MD
Associate Research Scientist in Pathology
Departments & Organizations
early breast carcinogenesis, development of companion diagnostic tests, in situ quantification of proteins and nucleic acids, development of prognostic and predictive biomarker signatures for breast and other cancers
- M.D., University of Vienna, 1992
- Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL.(2010). In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol. 2010 May;176(5):2131-8
- Neumeister VM, Sullivan CA, Lindner R, Lezon-Geyda K, Li J, Zavada J, Martel M, Glazer PM, Tuck DP, Rimm DL, Harris (2012). Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res Treat. 2012 Nov;136(1):67-75.
- Neumeister VM, Anagnostou V, Siddiqui S, England AM, Zarrella ER, Vassilakopoulou M, Parisi F, Kluger Y, Hicks DG, Rimm DL (2012). Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst. 2012 Dec 5;104(23):1815-24.